Solace provides a patient-centric advocacy layer that operates alongside clinical care, pairing individuals with experienced nurses and care specialists who coordinate appointments, manage logistics, and surface treatment options. Accessible via a HIPAA-compliant text, phone, and video platform, the company currently supports more than 20,000 patients each month and works with a national network of over 2,000 professional advocates. Founded in 2022 by CEO Jeremy Gurewitz and Chief Product Officer Sara Sargent, Solace addresses the costly gaps between diagnosis and treatment that leave nearly 40% of Americans delaying or avoiding care. The company reports 10× year-over-year growth, underscoring rising demand as healthcare complexity and costs climb. Revenue figures are not disclosed, but the business is now valued at more than $1 billion following its latest round. With fresh capital, Solace plans to scale its advocate network, invest further in its technology platform and clinical research, and deepen partnerships with payers and providers to embed advocacy earlier in the care journey.

Total raised

$204M

Funding rounds

3

Latest round

Series C

Latest activity

Feb 2026